Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A complete clinical guide to romosozumab adverse events, what happens when you stop Evenity, rebound bone loss data, cardiovascular warnings, and how to transition safely after the 12-month course.
Read clinical reviewA clinician-reviewed guide to delayed-onset side effects of romosozumab (Evenity), including cardiovascular risk, osteonecrosis of the jaw, atypical femur fractures, hypersensitivity reactions, and FAERS post-market data.
Read clinical reviewA comprehensive breakdown of romosozumab adverse event rates from FRAME, ARCH, BRIDGE, and STRUCTURE trials, plus FDA label data and post-market surveillance findings.
Read clinical reviewA clinical deep-dive into Evenity (romosozumab) side effects, including potentially permanent adverse events such as cardiovascular injury, osteonecrosis of the jaw, and atypical femur fractures. Reviewed by the HealthRX medical team.
Read clinical reviewA clinical deep-dive into the rare but serious adverse events associated with romosozumab (Evenity), including cardiovascular risk, osteonecrosis of the jaw, atypical femur fractures, and hypocalcemia, with trial data and FDA guidance.
Read clinical reviewA clinical breakdown of Evenity (romosozumab) adverse events by severity grade and patient phenotype, including cardiovascular risk, injection-site reactions, and post-market FAERS data.
Read clinical review